Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection

Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection

Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide; however, accurate prognostic tools are still lacking. We aimed to identify immunohistochemistry (IHC)-based signature as a prognostic classifier to predict recurrence and survival in patients with HCC at Barcelona Clinic Liver...

Full description

Bibliographic Details
Main Authors: Yannan Bai, Yuane Lian, Xiaoping Chen, Jiayi Wu, Jianlin Lai, Funan Qiu, Songqiang Zhou, Zijing Zhu, Yifeng Tian, Yaodong Wang, Yinghong Yang, Maolin Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
immunohistochemistry
prognostic marker
classifier
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.616263/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.616263/full

Similar Items